REQUEST A DEMO
Total
USD $0.00
Search more companies

Nova-Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Nova-Pharma Sp. z o.o. Profile Updated: June 01, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Nova-Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was first established on April 30, 2012. The total number of employees is currently 1 (2015). Its total assets grew by 2.17% over the same period.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Nova-Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Nova-Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Nova-Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nova-Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 30, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Nova-Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
N/A
Total operating revenue
N/A
Operating profit (EBIT)
97.47%
Net Profit (Loss) for the Period
97.47%
Total assets
2.17%
Total equity
-0.51%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-19.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?